Richard Kho

Richard is a seasoned healthcare and technology executive offering deep industry expertise across pharma, med tech, and AI in healthcare.  In his current role as Chief Operating Officer at Iterative Scopes, he is helping to develop and implement AI technologies to support gastroenterologists in clinical decision support, leading to earlier diagnosis and treatment of colon cancer and inflammatory bowel disease.  In his prior roles at PicnicHealth and Komodo Health, he worked with patients, patient foundations, academic research institutions, and biopharma companies to advance medical research and to accelerate the development and adoption of new therapies. In his prior roles at Amgen, Onyx Pharma, Genentech, and InVentiv Health, Richard helped support the development and launch of multiple therapies across varying disease areas, including oncology, rheumatology, and critical care medicine.  He earned a Ph.D. degree in toxicology and a B.S. degree in biochemistry from The University of California, Riverside, and an M.B.A. degree from The University of Southern California.